Debridamento periodontal como abordagem terapêutica para pacientes fumantes com periodontite agressiva
Danielle de Genaro Modanese.
Dissertação
Português
D61
2013.
59 f. : il.
Dissertação (Mestrado em Patologia Bucal) - Centro de Pesquisas Odontológicas São Leopoldo Mandic, Campinas - SP.
O objetivo do presente estudo foi avaliar o efeito da terapia de debridamento periodontal (DBR), em pacientes fumantes, portadores de periodontite agressiva generalizada (PAG). Para a realização deste estudo, de delineamento prospectivo, paralelo e cego, foram selecionados 12 pacientes fumantes (PF)...
Ver mais
O objetivo do presente estudo foi avaliar o efeito da terapia de debridamento periodontal (DBR), em pacientes fumantes, portadores de periodontite agressiva generalizada (PAG). Para a realização deste estudo, de delineamento prospectivo, paralelo e cego, foram selecionados 12 pacientes fumantes (PF) e 12 não fumantes (PNF), diagnosticados com PAG, com um mínimo de 20 dentes, distribuídos em 4 quadrantes e pelo menos 8 dentes com profundidade de sondagem (PS)?5 mm, com sangramento à sondagem (SS), para análise clínica e imunoinflamatória. Todos os participantes foram submetidos à adequação bucal e orientação de higiene oral. Após terapia inicial, os pacientes foram divididos em dois grupos: PF e PNF e ambos foram tratados por DBR (consistindo de 1 sessão de 60 minutos por meio de instrumentação ultrassônica). Os parâmetros clínicos avaliados foram: Índice de Placa (IP),Índice de Sangramento Gengival (ISG), SS,PS e Nível de Inserção Clínico (NIC), para boca toda e para os 8 sítios selecionados, incluindo a Posição da Margem gengival (PMG) para os sítios. A análise imunoinflamatória foi realizada por meio de reação imunoenzimática (ELISA) para os seguintes mediadores: RANKL, OPG, IL-6 e TNF-?. Todas as análises foram realizadas no baseline e 30, 90 e 180 dias após os tratamentos. Quando analisados os dados de boca-toda, pode-se observar uma redução significativa entre baseline e 180 dias para IP e ISG, tanto para os PF como para os NF. Entretanto para PS houve diferença significativa somente para o grupo PNF (p<0,05), enquanto que, para NIC não houve diferença. Na análise dos sítios, pode-se observar uma redução significativa entre baseline e 180 dias para IP, PS e NIC e um aumento na PMG, tanto para os PF como para os NF (p<0,05). Quanto à concentração de citocinas, ambos os grupos apresentaram redução estatística (p<0,05) dos níveis de IL-6, TNF-? e RANKL, porém sem diferença entre os grupos. OPG apresentou apenas um aumento numérico, mas sem diferença estatística. Dentro dos limites deste estudo, concluímos que o DBR pode ser uma alternativa para tratar PF com PAG, entretanto, os não fumantes apresentaram resultados mais favoráveis que os fumantes.
The aim of the present study was to evaluate the effects of Periodontal Debridement Therapy (DBR) in smokers with Generalized Aggressive Periodontitis (GAP). A prospective parallel blind study was performed. Twelve smokers (S) and 12 non-smokers (NS), diagnosed with GAP, with a minimum of 20 teeth distributed amongst the four quadrants, and with at least eight teeth with a probing depth (PD) of ?5 mm and bleeding on probing (BOP), were selected for clinical and immunoinflammatory assessment. All participants were assessed for oral suitability and advised on oral hygiene. Following initial therapy, the patients were divided in to two groups: S and NS. Both groups were treated by DBR, consisting of one session of 60 minutes using ultrasonic instrumentation. Plaque Index (PI), Gingival Bleeding Index (GBI), BOP, PD and Clinical Attachment Level (CAL) were evaluated for the whole mouth and for the eight selected sites, including the Gingival Margin Position (GMP). Immuno inflammatory analysis for RANKL, OPG, IL-6 and TNF-?, was carried out via enzyme-linked immunosorbent assay (ELISA). All analyses were performed at baseline, 30, 90 and 180 days after treatment. When analyzing the data for the whole mouth, a significant reduction between baseline and 180 days was observed for PI and GBI, both for S and NS. In terms of PD, however, a significant difference was only noted for group NS (p<0.05), whilst there was no significant difference for CAL. A significant reduction was observed for site analysis between baseline and 180 days for PI, PD and CAL, with an increase noted for GMP, both for S and NS (p<0.05). Both groups presented a significant reduction (p<0.05) in the concentration of the interleukins IL-6, TNF-? and RANKL; however, no difference was observed between the groups. OPG presented a single increase in value, although it was not statistically significant. Within the limits of the present study, it is concluded that DBR could be an alternative treatment for S with GAP; however, non-smokers demonstrated more favorable results than smokers.
Key words: Aggressive periodontitis. Smoke. Tobacco. Periodontal debridement. Ver menos
The aim of the present study was to evaluate the effects of Periodontal Debridement Therapy (DBR) in smokers with Generalized Aggressive Periodontitis (GAP). A prospective parallel blind study was performed. Twelve smokers (S) and 12 non-smokers (NS), diagnosed with GAP, with a minimum of 20 teeth distributed amongst the four quadrants, and with at least eight teeth with a probing depth (PD) of ?5 mm and bleeding on probing (BOP), were selected for clinical and immunoinflammatory assessment. All participants were assessed for oral suitability and advised on oral hygiene. Following initial therapy, the patients were divided in to two groups: S and NS. Both groups were treated by DBR, consisting of one session of 60 minutes using ultrasonic instrumentation. Plaque Index (PI), Gingival Bleeding Index (GBI), BOP, PD and Clinical Attachment Level (CAL) were evaluated for the whole mouth and for the eight selected sites, including the Gingival Margin Position (GMP). Immuno inflammatory analysis for RANKL, OPG, IL-6 and TNF-?, was carried out via enzyme-linked immunosorbent assay (ELISA). All analyses were performed at baseline, 30, 90 and 180 days after treatment. When analyzing the data for the whole mouth, a significant reduction between baseline and 180 days was observed for PI and GBI, both for S and NS. In terms of PD, however, a significant difference was only noted for group NS (p<0.05), whilst there was no significant difference for CAL. A significant reduction was observed for site analysis between baseline and 180 days for PI, PD and CAL, with an increase noted for GMP, both for S and NS (p<0.05). Both groups presented a significant reduction (p<0.05) in the concentration of the interleukins IL-6, TNF-? and RANKL; however, no difference was observed between the groups. OPG presented a single increase in value, although it was not statistically significant. Within the limits of the present study, it is concluded that DBR could be an alternative treatment for S with GAP; however, non-smokers demonstrated more favorable results than smokers.
Key words: Aggressive periodontitis. Smoke. Tobacco. Periodontal debridement. Ver menos
Debridamento periodontal como abordagem terapêutica para pacientes fumantes com periodontite agressiva
Danielle de Genaro Modanese.
Debridamento periodontal como abordagem terapêutica para pacientes fumantes com periodontite agressiva
Danielle de Genaro Modanese.
Exemplares
Nº de exemplares: 1
Não existem reservas para esta obra